Literature DB >> 19269353

A unique 970kb microdeletion in 9q33.3, including the NR5A1 gene in a 46,XY female.

Anneke van Silfhout1, Annemieke M Boot, Trijnie Dijkhuizen, Annemieke Hoek, Rien Nijman, Birgit Sikkema-Raddatz, Conny M A van Ravenswaaij-Arts.   

Abstract

We report on a female patient with XY sex reversal with clitoromegaly, neonatal male testosterone and AMH levels, and a normal urine steroid profile. Array CGH revealed a de novo microdeletion of chromosome 9q33.3, including the NR5A1 gene. NR5A1 encodes for the steroidogenic factor-1 (SF-1) and heterozygous mutations in this gene were recently identified as an important cause of XY sex reversal. However, a deletion of NR5A1 has only been reported once. Patients with a mutation in NR5A1, have severe underandrogenisation with mild testicular dysgenesis. Müllerian structures may be present, while postnatal testosterone levels may be normal. This points towards a predominantly early embryonic effect of low, local, androgen levels, with or without reduced AMH levels. We recommend not only NR5A1 mutation screening, but also copy number analysis in patients with 46,XY sex reversal of unknown cause, even in the absence of dysmorphisms or congenital abnormalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269353     DOI: 10.1016/j.ejmg.2009.02.009

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  11 in total

1.  46,XY disorder of sex development and developmental delay associated with a novel 9q33.3 microdeletion encompassing NR5A1.

Authors:  Tracy Brandt; Leah Blanchard; Khyati Desai; Saroj Nimkarn; Ninette Cohen; Lisa Edelmann; Lakshmi Mehta
Journal:  Eur J Med Genet       Date:  2013-09-20       Impact factor: 2.708

Review 2.  Steroidogenic factor-1 and human disease.

Authors:  Ranna El-Khairi; John C Achermann
Journal:  Semin Reprod Med       Date:  2012-10-08       Impact factor: 1.303

3.  Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.

Authors:  Steven M Harrison; Ian M Campbell; Melise Keays; Candace F Granberg; Carlos Villanueva; Grace Tannin; Andrew R Zinn; Diego H Castrillon; Chad A Shaw; Pawel Stankiewicz; Linda A Baker
Journal:  Am J Med Genet A       Date:  2013-08-05       Impact factor: 2.802

Review 4.  Steroidogenic factor-1 (SF-1, NR5A1) and human disease.

Authors:  Bruno Ferraz-de-Souza; Lin Lin; John C Achermann
Journal:  Mol Cell Endocrinol       Date:  2010-11-13       Impact factor: 4.102

Review 5.  New technologies for the identification of novel genetic markers of disorders of sex development (DSD).

Authors:  A Bashamboo; S Ledig; P Wieacker; J C Achermann; J Achermann; K McElreavey
Journal:  Sex Dev       Date:  2010-07-03       Impact factor: 1.824

Review 6.  Mammalian sex determination—insights from humans and mice.

Authors:  Stefanie Eggers; Andrew Sinclair
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

7.  The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.

Authors:  Helena Campos Fabbri; Juliana Gabriel Ribeiro de Andrade; Fernanda Caroline Soardi; Flávia Leme de Calais; Reginaldo José Petroli; Andréa Trevas Maciel-Guerra; Gil Guerra-Júnior; Maricilda Palandi de Mello
Journal:  BMC Med Genet       Date:  2014-01-10       Impact factor: 2.103

8.  The importance of the multiplex ligation-dependent probe amplification in the identification of a novel two-exon deletion of the NR5A1 gene in a patient with 46,XY differences of sex development.

Authors:  Orsolya Nagy; Judit Kárteszi; Marianna Hartwig; Rita Bertalan; Eszter Jávorszky; Éva Erhardt; Attila Patócs; Tamás Tornóczky; István Balogh; Anikó Ujfalusi
Journal:  Mol Biol Rep       Date:  2019-07-23       Impact factor: 2.316

9.  A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development.

Authors:  Joyce Y Wu; Ivan N McGown; Lin Lin; John C Achermann; Mark Harris; David M Cowley; Salim Aftimos; Kristen A Neville; Catherine S Choong; Andrew M Cotterill
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

10.  Submicroscopic copy-number variations associated with 46,XY disorders of sex development.

Authors:  Masafumi Kon; Maki Fukami
Journal:  Mol Cell Pediatr       Date:  2015-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.